ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

COVID-19 pill for at-home treatment in trials by Japan's Shionogi

Drug poised to compete with candidates from Roche-owned Chugai and Merck

Commuters in Tokyo: At-home treatments for COVID-19 hold the potential to ease the strain on hospitals. (Photo by Kei Higuchi)

OSAKA -- Japanese pharmaceutical company Shionogi has begun a Phase 1 trial of an antiviral pill for COVID-19 patients with light symptoms, joining peers worldwide in seeking a therapy to treat infected people at home.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more